Enzyme-linked immunosorbent assay with purified Trypanosoma cruzi excreted superoxide dismutase

Clinical Biochemistry

Volumn 43, Issue 15, 2010, Pages 1257-1264

  Mateo, Héctor ^a   Sánchez Moreno, Manuel ^a   Marín, Clotilde ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Chagas disease; SOD excreted; Superoxide dismutase; Trypanosoma cruzi

Indexed keywords

AMMONIUM SULFATE; SUPEROXIDE DISMUTASE;

ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME ISOLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PURIFICATION; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOGENICITY; INTERMETHOD COMPARISON; ION EXCHANGE CHROMATOGRAPHY; ISOELECTRIC POINT; LEISHMANIASIS; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRYPANOSOMA CRUZI;

ANIMALS; ANTIBODIES, PROTOZOAN; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MICE; ROC CURVE; SENSITIVITY AND SPECIFICITY; SUPEROXIDE DISMUTASE; TRYPANOSOMA CRUZI;

EID: 77956728991     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.07.015     Document Type: Article

References (47)

1. Available on line. http://www.who.int/tdr/diseases/chagas/ (accessed on 7 May 2009).
2. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 2000, 1:92-100.
3. Salles N.A., Sabino E.C., Cliquet M.G., et al. Risk of exposure to Chagas disease among seroreactive Brazilian blood donors. Transfusion 1996, 45:969-973.
4. Wendel S. Transfusion-transmitted Chagas disease. Curr Opin Hematol 1998, 5:406-411.
5. Oelemann W.M.R., Teixeira M.G.M., Verissimo-da-Costa G.C., et al. Evaluation of three commercial enzyme-linked immunosorbent assays for diagnosis of Chagas disease. J Clin Microbiol 1998, 36:2423-2427.
6. Gomes M.L., Galvão L.M.C., Macedo A.M., et al. Chaga'disease diagnosis: comparative analysis of parasitologic, molecular, and serologic methods. Am J Trop Méd Hyg 1999, 60:205-210.
7. Marcon G.E., Andrade P.D., de Albuquerque D.M., et al. Use of a nested polymerase chain reaction (N-PCR) to detect Trypanosoma cruzi in blood samples from chronic chagasic patients and patients with doubtful serologies. Diagn Microbiol Infect Dis 2002, 43:39-43.
8. Schechter M., Voller A., Marinkelle C.J., et al. A purified Trypanosoma cruzi specific glycoprotein for discriminative serological diagnosis of South American trypanosomiasis (Chagas disease). Lancet 1983, 22:939-941.
9. Ronaldo M.C., D'Escoffier L.N., Salles J.M., et al. Characterization and expression of proteases during T. cruzi metacyclogenesis. Exp Parasitol 1991, 73:44-51.
10. Krautz G.M., Peterson J.D., Godsel L.M., et al. Human antibody responses of Trypanosoma cruzi 70-kD heat-shock proteins. Am J Trop Med Hyg 1998, 58:137-143.
11. Telles S., Abate T., Slezynger T., et al. Trypanosoma cruzi ubiquitin as an antigen in the differential diagnosis of Chagas disease and leishmaniasis. FEMS Immunol Med Microbiol 2003, 37:23-28.
12. Frash A.C.C. Transialidase, SAPA amino acid repeats and the relationship between Trypanosoma cruzi and the mammalian host. Parasitol 1994, 108:37-44.
13. Umezawa E.S., Nascimento M.S., Stolf A.M. Enzyme-linked immunosorbent assay with Trypanosoma cruzi excreted-secreted antigens (TESA-ELISA) for serodiagnosis of acute and chronic Chagas disease. Diagn Microbiol Infect Dis 2001, 39:169-176.
14. Franco da Silveira F., Umezawa E.S., Luquetti A.O. Chagas disease: recombinant Trypanosoma cruzi antigens for serological diagnosis. Trends Parasitol 2001, 17:286-291.
15. Silveira-Lacerda E.P., Silva A.G., Favorito S., et al. Chagas disease: application of TESA-Blot in inconclusive sera from a Brazilian blood bank. Vox Sang 2004, 87:204-207.
16. Fridovich I. Superoxide dismutases: an adaptation to a paramagnetic gas. J Biol Chem 1989, 264:7761-7764.
17. McCord J.M., Fridovich I. Superoxide dismutase: the first twenty years (1968-1988). Free Radic Biol Med 1998, 5:363-369.
18. Bannister J.V., Bannister W.H., Rottilio G. Aspects of the structure, function and application of superoxide dismutase. Crit Rev Biochem 1987, 22:111-180.
19. Boveris A., Stoppani A.O. Hydrogen peroxide generation in Trypanosoma cruzi. Experienta 1977, 33:1306-1308.
20. Ismail S.O., Paramchuck W.J., Bhatia J.A., et al. Molecular cloning and characterization of two iron superoxide dismutase cDNAs from Trypanosoma cruzi: differential and stage specific expression. Mol Biochem Parasitol 1997, 86:187-197.
21. Temperton N.J., Wilkinson S.R., Kelly M. Cloning of a Fe-superoxide dismutase gene homologue from Trypanosoma cruzi. Mol Biochem Parasitol 1997, 90:203-221.
22. Mateo H., Marín C., Pérez-Cordón G., et al. Purification and biochemical characterization of four iron superoxide dismutase activities in Tripanosoma cruzi. Mem Inst Oswaldo Cruz 2008, 103:271-276.
23. Villagrán M.E., Marín C., Rodríguez-González I., et al. Use of an iron superoxide dismutase excreted by Trypanosoma cruzi in the diagnosis of Chagas disease: seroprevalence in rural zones of the state of Queretaro, Mexico. Am J Trop Med Hyg 2005, 73:510-516.
24. Marín C., Rodríguez I., Hitos A., et al. Purification and characterization of two iron superoxide dismutases of Phytomonas sp. isolated from Euphorbia characias (plant trypanosomatids). Parasitol 2004, 129:79-86.
25. Bradford M.M. A refined and sensitive method for the quantification of microquantities of protein-dye binding. Anal Biochem 1976, 72:248.
26. Beyer W.F., Fridovich I. Assaying for superoxide dismutase activity: some large consequences of minor changes in conditions. Anal Biochem 1987, 161:559-566.
27. Bergmeyer H.U. Methods of enzymatic analysis 1981, Academic Press, New York. 3rd edn.
28. Bécuwe P., Gratepanche S., Fourmaux M.N., et al. Characterization of iron-dependent endogenous superoxide dismutase of Plasmodium falciparum. Mol Biochem Parasitol 1996, 76:125-134.
29. Camargo M.E., Segura E.L., Kagan I.G., et al. Normalización del diagnóstico serológico de la enfermedad de Chagas en Las Américas: evaluación de tres años de colaboración. Bol Oficina Sanit Panam 1987, 102:449-463.
30. Sousa-Jurado F., Zumaquero J.L., Reyes P.A., et al. Factores bióticos y abióticos que determinan la seroprevalencia de anticuerpos contra Trypanosoma cruzi en el municipio de Bravo, Puebla, México. Salud Pública Mex 2004, 46:39-48.
31. Marín C., Longoni S.E., Rodríguez-González I., et al. Leishmania infantum: use of excreted superoxide dismutase in ELISA and Western blotting for serologic diagnostic in naturally infected dogs. Parasitol Res 2007, 101:801-808.
32. Marín C., Rodríguez-González I., Sánchez-Moreno M. Identification of excreted iron superoxide dismutase for the diagnosis of Phtytomonas. Mem Inst Oswaldo Cruz 2006, 101:649-654.
33. Affranchino J.L., Ibañez C.F., Luquetti A.O., et al. Identification of a Trypanosoma cruzi antigen that is shed during the acute phase of Chagas disease. Mol Biochem Parasitol 1989, 15:221-228.
34. Gonçalves M.F., Umezawa E.S., Katzin A.M., et al. Trypanosoma cruzi: shedding of surface antigens as membrane vesicles. Exp Parasitol 1991, 72:43-53.
35. Jazín E.E., Luquetti A.O., Rassi A., et al. Shift of excretory-secretory immunogens of Trypanosoma cruzi during human Chagas disease. Infect Immun 1991, 59:2189-2191.
36. Umezawa E.S., Nascimento M.S., NJr Kesper, et al. Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas disease. J Clin Microbiol 1996, 34:2143-2147.
37. Camargo M.E. An appraisal of Chagas disease serodiagnosis. Chagas disease (American trypanosomiasis): its impact on transfusion and clinical medicine. ISBT Brazil'92, Sao Paulo, Brazil 1992, 165-168. S. Wendel, Z. Brener, M.E. Camargo, A. Rassi (Eds.).
38. Levin M., Mesri E., Benarous R., et al. Identification of major Trypanosoma cruzi antigenic determinants in chronic Chagas disease. Am J Trop Med Hyg 1989, 41:530-538.
39. Luquetti A.O. Use of Trypanosoma cruzi defined proteins for diagnosis-multicentre trial. Serological and technical aspects. Mem Inst Oswaldo Cruz 1990, 85:450-497.
40. Goldenberg S., Krieger M.A., Lafaille J.J., et al. Use of Trypanosoma cruzi antigens in the immunological diagnosis of Chagas disease. Mem Inst Butantan 1991, 53:71-76.
41. Umezawa E.S., Bastos S., Camargo M.E., et al. Evaluation of recombinant antigens for serodiagnosis of Chagas disease in South and Central. Am J Clin Microbiol 1999, 37:1554-1560.
42. Weston D., Patel B., Van Voorhis W.C. Virulence in Tripanosoma cruzi infection correlates with the expression of a distinct family of sialidase superfamily genes. Mol Biochem Parasitol 1999, 98:105-116.
43. Berrizbeitia M., Ndao M., Bubis J., et al. Purified excreted-secreted antigens from Trypanosoma cruzi trypomastigotes as tools for diagnosis of Chagas disease. J Clin Microbiol 2006, 44:291-296.
44. Pinho R.T., Vannier-Santos M.A., Alves C.R., et al. Effect of Trypanosoma cruzi released antigens binding to non-infected cells on anti-parasite antibody recognition and expression of extracellular matrix components. Acta Trop 2002, 83:103-115.
45. Silber A.M., Marcipar I.S., Roodveldt C., et al. Trypanosoma cruzi: identification of a galactosebinding protein that binds to cell surface of human erythrocytes and is involved in cell invasion by the parasite. Exp Parasitol 2002, 100:217-225.
46. Nakazawa M., Rosa D.S., Pereira V.R., et al. Excretory-secretory antigens of Trypanosoma cruzi are potentially useful for serodiagnosis of chronic Chagas disease. Clin Diagn Lab Immunol 2001, 8:1024-1027.
47. Gutierrez R., Angulo V.M., Tarazona Z., et al. Comparison of four serological tests for the diagnosis of Chagas disease in a Colombian endemic area. Parasitol 2004, 129:439-444.